prospective comparison protracted infusional weekly bolus cisplatin metastatic colorectal carcinoma Mid-Atlantic Oncology Program study eighty-four patients advanced measurable colorectal cancer chemotherapy prospective clinical trial Mid-Atlantic Oncology Program MAOP value weekly cisplatin protracted schedule infusion PIF weeks weeks liver primary indicator lesion study group tumor measurements radiographic confirmation response rate PIF arm confidence interval CI CI arm weekly cisplatin PIF median survival times months groups Weekly cisplatin effectiveness PIF colorectal carcinoma 